跳至主要内容
临床试验/IRCT201604193924N3
IRCT201604193924N3已完成3 期

Comparison of effectiveness of Omega3 supplementation on poly cystic ovary syndrome(PCOs) symptoms and metabolic syndrome according of the NIH criteria

Vice chancllor for Isfahan University of Medical Sciences0 个研究点目标入组 88 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
88

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 40 years(—)
性别
Female

入选标准

  • inclusion criteria: Patients who have informed consent ; PCOS disease, according to the NIH3 ; age between 18-40 ; Exclusion criteria: smoking, use of oral pregnancy pill or alcohol or fish oil in 3 month ago or into the study ; pregnancy; have disease of kidney or liver or heart or thyroid ; diabetes ; hyperprolactinemia ; Cushing, Adrenal congenital hyperplasia, menopause ; the patient withdrew into the study ; Failure to follow the next visit

排除标准

  • 未提供

研究者

发起方
Vice chancllor for Isfahan University of Medical Sciences

相似试验